|
WO2018098348A1
|
|
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a cd38 inhibitor and methods of use thereof
|
|
WO2018098168A1
|
|
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a programmed death-ligand 1 (pd-l1) inhibitor and methods of use thereof
|
|
US2018127356A1
|
|
Phenyl and pyridinyl hydroxamic acids
|
|
EP3535275A1
|
|
Pharmaceutical combinations comprising a histone deacetylase inhibitor and a bcl-2 inhibitor and methods of use thereof
|
|
EP3532054A1
|
|
Pharmaceutical combinations comprising a histone deacetylase inhibitor and epothilone and methods of use thereof
|
|
WO2018081585A1
|
|
Pharmaceutical combinations comprising a histone deacetylase inhibitor and an aurora kinase inhibitor and methods of use thereof
|
|
EP3496751A1
|
|
Pharmaceutical combinations of histone deacetylase 6 inhibitors and cd20 inhibitory antibodies and uses thereof
|
|
EP3445364A1
|
|
Hdac inhibitors, alone or in combination with btk inhibitors, for treating chronic lymphocytic leukemia
|
|
US2019046529A1
|
|
Increasing expression of interferon regulated genes with combinatons of histone deacetylase inhibitors and immunomodulatory drugs
|
|
WO2017075192A1
|
|
Hdac inhibitors for the treatment of diabetic peripheral neuropathy
|
|
AR104935A1
|
|
CRYSTAL FORMS OF A HISTONA DEACETILASA INHIBITOR
|
|
EP3303304A1
|
|
Methods of making protein deacetylase inhibitors
|
|
US2016339022A1
|
|
Treatment of neuroblastoma with histone deacetylase inhibitors
|
|
WO2016090230A1
|
|
Pyrimidine hydroxy amide compounds for treating peripheral neuropathy
|
|
CA2963681A1
|
|
Induction of gata2 by hdac1 and hdac2 inhibitors
|
|
WO2016007423A1
|
|
Treatment of leukemia with histone deacetylase inhibitors
|
|
US2015239869A1
|
|
Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
|
|
US2015176076A1
|
|
Histone deacetylase 6 (hdac6) biomarkers in multiple myeloma
|
|
KR20160092018A
|
|
Combinations of histone deacetylase inhibitors and immunomodulatory drugs
|
|
US2015105384A1
|
|
Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors
|
